Olaparib: A Revolutionary Treatment for Cancer Olaparib (brand name Lynparza) is an innovative medication primarily used in the treatment of certain types of cancer. As a member of the class…
Larotrectinib: A Targeted Therapy for TRK Fusion Cancer What is Larotrectinib? Larotrectinib is an oral cancer treatment designed to specifically target NTRK gene fusions, a rare genetic abnormality that can…
Lorlatinib: A Targeted Therapy for ALK-Positive Lung Cancer Lorlatinib is a next-generation tyrosine kinase inhibitor (TKI) designed to treat ALK-positive non-small cell lung cancer (NSCLC). Approved by the FDA and…
Ponatinib: Uses, Benefits, Dosage, and Side Effects Ponatinib is a prescription medication used to treat certain types of leukemia. Marketed under the brand name Iclusig, Ponatinib is a tyrosine kinase…
Reviews
There are no reviews yet.